The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
PARPi effectiveness after CDK4/6i in BRCA1- and BRCA2-associated HR+/HER2- advanced breast cancer: Results from the multicenter real-world PAMBRACA study.
 
Emma Zattarin
Honoraria - Lilly
Travel, Accommodations, Expenses - Lilly; Roche
 
Antonio Marra
Consulting or Advisory Role - AstraZeneca; Menarini Group
Speakers' Bureau - Lilly; Roche
Travel, Accommodations, Expenses - AstraZeneca; Daiichi Sankyo; Lilly
 
Antonella Palazzo
Consulting or Advisory Role - AstraZeneca/Daiichi Sankyo; Exact Sciences; Ipsen; Lilly; Novartis; Pfizer
Research Funding - AstraZeneca/Daiichi Sankyo (Inst); Pfizer (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Novartis; Pfizer
 
Gaia Griguolo
Consulting or Advisory Role - Gilead Sciences; Menarini; Seagen
Speakers' Bureau - Lilly; MSD
Travel, Accommodations, Expenses - Daiichi Sankyo/Astra Zeneca; Gilead Sciences; Lilly; Novartis; Pfizer
 
Claudio Vernieri
Consulting or Advisory Role - Daiichi Sankyo/Astra Zeneca; Lilly; Menarini Group; Novartis; Pfizer
Speakers' Bureau - Accademia Nazionale Di Medicina (ACCMED); AstraZeneca; Istituto Gentili; Lilly; Menarini Group; MSD; Novartis; Pfizer
Research Funding - Roche
 
Julian Etessami
No Relationships to Disclose
 
Letizia Pontolillo
Speakers' Bureau - Daiichi Sankyo/Astra Zeneca
Travel, Accommodations, Expenses - Gilead Sciences; Lilly; Pfizer
 
Arianna Daneri
No Relationships to Disclose
 
Matteo De Monte
No Relationships to Disclose
 
Ornella Ponzoni
No Relationships to Disclose
 
Martina Manni
No Relationships to Disclose
 
Federica Domati
No Relationships to Disclose
 
Giuseppe Curigliano
Leadership - ESMO; ESMO; ESMO Open; European Society of Breast Cancer Specialists (EUSOMA=
Honoraria - Ellipses Pharma
Consulting or Advisory Role - AstraZeneca; Blueprint Medicines; Boehringer Ingelheim; Bristol-Myers Squibb; Celcuity; Daichi-Sankyo; Exact Sciences; Foundation Medicine; Gilead Sciences; GlaxoSmithKline; Guardant Health; Hengrui Therapeutics; Lilly; Menarini; Merck; Novartis; Pfizer; Roche/Genentech; Samsung; Seagen; Veracyte
Speakers' Bureau - AstraZeneca; Daiichi Sankyo; Exact Sciences; Foundation Medicine; Gilead Sciences; Lilly; Menarini; Novartis; Pfizer; Roche/Genentech; Samsung; Seagen
Research Funding - Merck (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Daichii Sankyo; Pfizer; Roche/Genentech
 
Massimo Dominici
No Relationships to Disclose
 
Laura Cortesi
Honoraria - AstraZeneca; Daiichi Sankyo Europe GmbH; Gilead Sciences; MSD; Novartis; Pfizer; Roche/Genentech
Consulting or Advisory Role - MSD; Novartis; Pfizer
Speakers' Bureau - AstraZeneca; Gilead Sciences; MSD Oncology; Novartis
Travel, Accommodations, Expenses - AstraZeneca; Daiichi Sankyo Europe GmbH; Gilead Sciences
 
Matteo Lambertini
Consulting or Advisory Role - AstraZeneca; Exact Sciences; Gilead Sciences; Lilly; Menarini; MSD; Novartis; Pfizer; Pierre Fabre; Roche; Seagen
Speakers' Bureau - AstraZeneca; Daiichi Sankyo; Gilead Sciences; Ipsen; Knight Therapeutics; Libbs; Lilly; Menarini; Novartis; Pfizer; Roche; Sandoz; Takeda
Research Funding - Gilead Sciences (Inst)
Travel, Accommodations, Expenses - Daiichi Sankyo Europe GmbH; Gilead Sciences; Roche
 
Angela Toss
Honoraria - AstraZeneca; Gilead Sciences; Lilly; MSD Oncology; Novartis; Pfizer; Seagen
Consulting or Advisory Role - Daiichi Sankyo/Astra Zeneca; Lilly; MSD/AstraZeneca; Novartis; Pfizer; Seagen
Travel, Accommodations, Expenses - Daiichi Sankyo/Astra Zeneca; Gilead Sciences